Clinical management of lung cancer patients during the outbreak of COVID-19 epidemic

Infectious Agents and Cancer

Xiaochun Zhang¹  Na Zhou¹  Li Wang¹  Man Jiang¹  Jialin Qu¹ 

[1] Precision Medicine Center of Oncology, The Affiliated Hospital of Qingdao University, Qingdao University, 16 Jiangsu Road, 266003, Qingdao, China;

关键词: COVID-19;    Lung cancer;    Patient management;   

DOI  :  10.1186/s13027-020-00322-7

来源: Springer

【 摘 要 】

The rapid growth of 2019 novel coronavirus (COVID-19) outbreak in Wuhan, China, at the early December 2019. COVID-19 spread all over the word just a few months. The outbreak of COVID-19 infection poses major threat to international health and economy. World Health Organization (WHO) announced that the new coronavirus was an international public health emergency on January 30, 2020. However, with the spread of COVID-19, the routine medical care of lung cancer patients was affected. Because lung cancer patients have low immunity after anti-tumor treatment, they should become the main targets for epidemic prevention. Lung cancer patients are increasingly concerned about the prevention of COVID-19. It is necessary to provide individualized medical treatment and management for lung cancer patients based on patients’ conditions and regional epidemic patterns.

【 授权许可】

CC BY